• By Anni Griswold
    Comprehensive Ophthalmology, Cornea/External Disease, Retina/Vitreous

    A weekly roundup of ophthalmic news from around the web.

    Would you remove a dying man’s cataracts to fulfill his final wish to see his family? This surgeon did amid an intense backlash from her peers. NPR Health Shots

    temperature-sensitive surgical sealant could buy time for soldiers with traumatic eye injuries. The liquid gel morphs into a pliable semi-solid upon application, and surgeons later remove the sealant with cool water. University of Southern California

    A "clean face program" for kids may stem the spread of Chlamydia trachomatis, a cause of infectious blindness. But ‘clean’ may be in the eye of the beholder, according to a study suggesting that on-the-ground cleanliness assessments are unreliable. PLoS Neglected Tropical Diseases

    Spark Therapeutics posted a $65 million quarterly loss, double last year’s loss during this time. But there’s a silver lining – the company’s revenue rose during the same period, and most of the loss is associated with the cost of launching the retinal gene therapy, Luxturna. Healio

    The first eye drop supplemented with plant-derived omega-3 will soon appear on drugstore shelves in Europe. According to Novaliq, NovaTears+Omega-3 stabilizes the lipid layer of the tear film to improve the signs and symptoms of evaporative dry eye disease. Novaliq